A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes
= 130) follow-up. No patients declined their randomization arm. For all 261 randomized patients, the 1-year participant retention rate was 92.0% (240/261). This RCT confirms both patient and healthcare-provider enthusiasm for studies comparing different strategies for post-treatment surveillance. No patients withdrew consent post-randomization due to a preference for one study arm over the other. While clinical effectiveness and patient satisfaction remain to be analyzed, our reported rates of attrition can be used by others when designing similar studies.
Authors
- Parvaneh Fallah (ORCID: https://orcid.org/0000-0001-7885-2009)
- Mark Clemons (ORCID: https://orcid.org/0000-0001-9392-8219)
- Gregory R. Pond (ORCID: https://orcid.org/0000-0003-1033-0882)
- Gail Larocque (ORCID: https://orcid.org/0000-0001-9979-6659)
- Lisa Vandermeer (ORCID: https://orcid.org/0000-0001-5921-1441)
- Deanna Saunders
- Ana-Alicia Beltran-Bless (ORCID: https://orcid.org/0000-0003-4880-8167)
- Marie-France Savard (ORCID: https://orcid.org/0000-0002-7651-0870)
- Danielle Allard
- Kelly-Anne Baines
- John Hilton
- Terry Ng
- Kendra Primeau
- Alexander Kim
- Emma Himmelman
Institutions
- Juravinski Cancer Centre (CA)
- Ottawa Hospital (CA)
- Ottawa Hospital Research Institute (CA)
Publication Details
- Journal
- Current Oncology
- Published
- 2026-04-17
- DOI
- https://doi.org/10.3390/curroncol33040224
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00